{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Normal plasma levels of PF4 are low, on the order of 8 nmol/L.\n* The infusion of heparin transiently increases PF4 levels 15 to 30 fold for several hours by displacing PF4 from the vascular endothelial interface, with levels ranging from 75-100 nmol/L.\n* When administered as a therapeutic anticoagulant, heparin levels range from 0.2 to 0.4 IU/ml, or 100-200 nmol/L."}
{"final_json": [{"molecule_name": "PF4", "protein_target_name": null, "binding_metric": null, "value": "8", "unit": "nmol/L", "is_logarithmic": false}, {"molecule_name": "PF4", "protein_target_name": null, "binding_metric": null, "value": "75-100", "unit": "nmol/L", "is_logarithmic": false}, {"molecule_name": "heparin", "protein_target_name": null, "binding_metric": null, "value": "0.2-0.4", "unit": "IU/ml", "is_logarithmic": false}, {"molecule_name": "heparin", "protein_target_name": null, "binding_metric": null, "value": "100-200", "unit": "nmol/L", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The critical degree of sulfation to form the HIT-reactive heparin-PF4 antigenic complex was found to lie between 0.6 and 1.20 (i.e., 0.6 to 1.2 sulfate groups per carbohydrate monomer).\n* The average molecular weight of 2-O desulfated heparin is 10.5 kD, and its approximate degree of sulfation is 1.0 (5 sulfate groups per pentasaccharide, see FIG. 1), placing it well within the risk range for HIT antibody interaction (Greinacher A, et al., supra).\n* HIT antibody activation was also not observed with the synthetic pentasaccharide fondaparinux, which weighs about 1.7 kD."}
{"final_json": [{"molecule_name": "heparin-PF4 antigenic complex", "protein_target_name": null, "binding_metric": null, "value": "0.6 to 1.2", "unit": "sulfate groups per carbohydrate monomer", "is_logarithmic": false}, {"molecule_name": "2-O desulfated heparin", "protein_target_name": null, "binding_metric": null, "value": "10.5", "unit": "kD", "is_logarithmic": false}, {"molecule_name": "2-O desulfated heparin", "protein_target_name": null, "binding_metric": null, "value": "1.0", "unit": "sulfate groups per pentasaccharide", "is_logarithmic": false}, {"molecule_name": "fondaparinux", "protein_target_name": null, "binding_metric": null, "value": "1.7", "unit": "kD", "is_logarithmic": false}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, bioactivity metrics, numeric values, and units as required. The text primarily describes the invention, its objects, and methods of producing heparin analogs, but does not provide specific data that includes all four required components."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nWith linear sulfated polysaccharides of a constant chain length of 35 monosaccharides, the critical degree of sulfation to form the HIT antigen was between 0.6 and 1.2 sulfates per monosaccharide.\nFor sulfated carbohydrates in the range of commercially available heparins, HIT-mediated platelet activation was maximal at a degree of sulfation of 1.25.\nAs an example, a concentration of 50 nmol/L of sulfated polysaccharide was required for 50% maximal platelet activation at a molecular weight of 12.2 kD, approximately that of commercial unfractionated heparin.\nIn the case of heparin, the optimum molecular weight was actually found to be 4.8 kD (a hexadecasaccharide), near the molecular weight of commercially available low molecular weight heparins, but higher molecular weights also supported HIT-mediated platelet activation.\nThe fully anticoagulant pentasaccharide fondaparinux, with a molecular weight of 1.78 kD, failed to produce any platelet activation in the presence of HIT antibodies, regardless of the concentration of pentasaccharide used.\nThe typical concentration of the heparin solution can be from 1 to 10 percent heparin."}
{"final_json": [{"molecule_name": "sulfated polysaccharides", "protein_target_name": null, "binding_metric": null, "value": "0.6", "unit": null, "is_logarithmic": false}, {"molecule_name": "sulfated polysaccharides", "protein_target_name": null, "binding_metric": null, "value": "1.2", "unit": null, "is_logarithmic": false}, {"molecule_name": "sulfated carbohydrates", "protein_target_name": null, "binding_metric": null, "value": "1.25", "unit": null, "is_logarithmic": false}, {"molecule_name": "sulfated polysaccharide", "protein_target_name": null, "binding_metric": null, "value": "50", "unit": "nmol/L", "is_logarithmic": false}, {"molecule_name": "sulfated polysaccharide", "protein_target_name": null, "binding_metric": null, "value": "50", "unit": "%", "is_logarithmic": false}, {"molecule_name": "sulfated polysaccharide", "protein_target_name": null, "binding_metric": null, "value": "12.2", "unit": "kD", "is_logarithmic": false}, {"molecule_name": "heparin", "protein_target_name": null, "binding_metric": null, "value": "4.8", "unit": "kD", "is_logarithmic": false}, {"molecule_name": "fondaparinux", "protein_target_name": null, "binding_metric": null, "value": "1.78", "unit": "kD", "is_logarithmic": false}, {"molecule_name": "heparin", "protein_target_name": null, "binding_metric": null, "value": "1", "unit": "%", "is_logarithmic": false}, {"molecule_name": "heparin", "protein_target_name": null, "binding_metric": null, "value": "10", "unit": "%", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* With a degree of sulfation of 1.0 and a molecular weight of 10.5 kD, this heparin analog would be predicted to significantly trigger platelet activation in the presence of a HIT antibody and PF4.\n* Whereas unfractionated heparin actively stimulates platelet activation under these circumstances when provided in concentrations of 0.4 \u03bcmoles/L, the usual therapeutic anticoagulating concentration of this drug, the 2-O desulfated heparin analog by the method described does not activate platelets when studied in concentrations ranging from 0.78 \u03bcmoles/L to 100 \u03bcmoles/L.\n* For HIT platelet activation, amelioration of serotonin release was observed at a concentration of 2-O desulfated heparin as low as 3.13 \u03bcg/ml when in the \n\nNote that these sentences contain a molecule name (heparin or 2-O desulfated heparin), a bioactivity metric (platelet activation or serotonin release), a specific numeric value for that metric (0.4 \u03bcmoles/L, 0.78 \u03bcmoles/L, 100 \u03bcmoles/L, or 3.13 \u03bcg/ml), and a unit for that value (\u03bcmoles/L or \u03bcg/ml)."}
{"final_json": [{"molecule_name": "heparin", "protein_target_name": null, "binding_metric": null, "value": "1.0", "unit": null, "is_logarithmic": false}, {"molecule_name": "heparin", "protein_target_name": null, "binding_metric": null, "value": "10.5", "unit": "kD", "is_logarithmic": false}, {"molecule_name": "unfractionated heparin", "protein_target_name": null, "binding_metric": "platelet activation", "value": "0.4", "unit": "\u03bcmoles/L", "is_logarithmic": false}, {"molecule_name": "2-O desulfated heparin analog", "protein_target_name": null, "binding_metric": "platelet activation", "value": "0.78", "unit": "\u03bcmoles/L", "is_logarithmic": false}, {"molecule_name": "2-O desulfated heparin analog", "protein_target_name": null, "binding_metric": "platelet activation", "value": "100", "unit": "\u03bcmoles/L", "is_logarithmic": false}, {"molecule_name": "2-O desulfated heparin", "protein_target_name": null, "binding_metric": "serotonin release", "value": "3.13", "unit": "\u03bcg/ml", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe 2-O desulfated heparin produced by this procedure was a fine crystalline slightly off-white powder with less than 10 USP units/mg anticoagulant activity and less than 10 anti Xa units/mg anticoagulant activity.\nCompared with an average molecular weight of 13.1 kD for the starting material, ODS Heparin had an average molecular weight of 11.8 kD."}
{"final_json": [{"molecule_name": "2-O desulfated heparin", "protein_target_name": null, "binding_metric": null, "value": "<10", "unit": "USP units/mg", "is_logarithmic": false}, {"molecule_name": "2-O desulfated heparin", "protein_target_name": null, "binding_metric": null, "value": "<10", "unit": "anti Xa units/mg", "is_logarithmic": false}, {"molecule_name": "starting material", "protein_target_name": null, "binding_metric": null, "value": "13.1", "unit": "kD", "is_logarithmic": false}, {"molecule_name": "ODS Heparin", "protein_target_name": null, "binding_metric": null, "value": "11.8", "unit": "kD", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nFIG. 5 shows that unfractionated heparin at the usual therapeutic anticoagulant concentration of 0.4 \u03bcg/ml elicits release of >80% of total radio labeled serotonin in this system.\nFIG. 6 shows that when unfractionated heparin at the usual therapeutic anticoagulant concentration of 0.4 \u03bcg/ml is incubated with platelets and HIT-antibody positive serum, there is prominent CD62 expression on the surface of approximately 20% of platelets.\nThe test system mixture incorporated both 5 \u03bcl of 2-O desulfated heparin (0, 0.78, 1.56, 3.13, 6.25, 12.5, 25, 50 and 100 \u03bcg/ml final concentrations) and 5 \u03bcl of unfractionated heparin (either 0.1 or 0.5 U/ml final con \nSaline controls incubations were characterized by low expression of CD62 (<2% of platelets).\nFurthermore, while 0.4 \u03bcg/ml unfractionated heparin produced substantial platelet microparticle formation, 2-O desulfated heparin at 0.78 to 100 \u03bcg/ml stimulated no level of platelet microparticle formation above that of the saline control incubations (<5% activity)."}
{"final_json": [{"molecule_name": "unfractionated heparin", "protein_target_name": null, "binding_metric": null, "value": ">80%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "unfractionated heparin", "protein_target_name": null, "binding_metric": null, "value": "20%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "2-O desulfated heparin", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "<2%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "unfractionated heparin", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "2-O desulfated heparin", "protein_target_name": null, "binding_metric": null, "value": "<5%", "unit": "%", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nThe concentration of acetylcholine required to effect 50% relaxation (EC50; -log [M]) was significantly greater for the Control (\u22126.98\u00b10.06) compared to the HEP (\u22127.30\u00b10.06) or ODSHEP (\u22127.20\u00b10.05) groups (p<0.05).\nIn addition, there were no differences between LAD versus LCx vasodilator responses to incremental concentrations of A23187 (maximal relaxation=122\u00b14 and 120\u00b17% and EC50 log [M]=\u22127.18\u00b10.06 and \u22127.17\u00b10.09 for LAD and LCx, respectively) or sodium nitroprusside (maximal relaxation=129\u00b15 and 121\u00b14% and EC50 log [M] =\u22127.31\u00b10.02 and \u22127.29\u00b10.04 for LAD and LCx, respectively)."}
{"final_json": [{"molecule_name": "acetylcholine", "protein_target_name": null, "binding_metric": "pEC50", "value": "-6.98", "unit": null, "is_logarithmic": true}, {"molecule_name": "acetylcholine", "protein_target_name": null, "binding_metric": "pEC50", "value": "-7.30", "unit": null, "is_logarithmic": true}, {"molecule_name": "acetylcholine", "protein_target_name": null, "binding_metric": "pEC50", "value": "-7.20", "unit": null, "is_logarithmic": true}, {"molecule_name": "A23187", "protein_target_name": null, "binding_metric": "pEC50", "value": "-7.18", "unit": null, "is_logarithmic": true}, {"molecule_name": "A23187", "protein_target_name": null, "binding_metric": "pEC50", "value": "-7.17", "unit": null, "is_logarithmic": true}, {"molecule_name": "sodium nitroprusside", "protein_target_name": null, "binding_metric": "pEC50", "value": "-7.31", "unit": null, "is_logarithmic": true}, {"molecule_name": "sodium nitroprusside", "protein_target_name": null, "binding_metric": "pEC50", "value": "-7.29", "unit": null, "is_logarithmic": true}]}
